DeepMind's AlphaGenome Maps Every DNA Mutation — Sep 14, 2026
Unable to add items
Sorry, we're unable to add the item because your cart is already full.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Failed to remove from Wish List.
Please try again later
Adding to library failed
Please try again
Unable to follow podcast
Unable to unfollow podcast
-
Narrated by:
-
By:
Google just mapped every possible way a single DNA letter can go wrong.
Run time: 7:23
In today's episode:
- DeepMind maps all 9 billion possible DNA mutations
- UK proposes 44 new rules for medical AI
- Rural AI push meets skepticism from actual providers
- OpenEvidence restricts its best model over dual-use risk
- AI spots collapsed lungs in newborns, 87.6% sensitivity
- AI-measured organ volume linked to kidney cancer survival
- Claude Fable 5.1 and Mythos 5.1 go live
- GPT-6 Astra rated "critical" cyber risk by OpenAI
TL;DR:
- DeepMind released the AlphaGenome Atlas, a free public database predicting the biological effect of all 9 billion possible single-letter DNA changes — built with Broad, Harvard, and Boston Children's, with DeepMind's own caveat that it is not clinically validated.
- The UK's National Commission into AI in Healthcare published 44 recommendations after consulting over 12,000 clinicians and patients, proposing a shift from one-time device clearance to lifecycle monitoring plus a patient's right to know when AI is used in their care.
- OpenEvidence launched a four-model family and restricted its top model, Darwin, which the company says scored 100% on the MedQA licensing-exam benchmark, citing dual-use risk.
Sources cited:
- Google DeepMind
- GOV.UK
- OpenEvidence
- STAT News
- Pediatric Radiology
- Annals of Medicine
- Anthropic
- OpenAI
Subscribe: YouTube
medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.
adbl_web_anon_alc_button_suppression_t1
No reviews yet